Completed OBSERVATIONAL NCT01705210

Functional MRI Biomarkers of Cognitive Decrements in Diabetes

Sponsor: Maastricht University Medical Center

Conditions Diabetes Mellitus, Type 2 Metabolic Syndrome X Mild Cognitive Impairment

Updated 6 times since 2017 Last updated: Apr 9, 2015 Started: May 31, 2012 Primary completion: Apr 30, 2015 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Diabetes Mellitus, Type 2 and Metabolic Syndrome X, this trial is completed. The trial is conducted by Maastricht University Medical Center and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maastricht University Medical Center
Netherlands Organisation for Scientific Research
ZonMw: The Netherlands Organisation for Health Research and Development

Data source: Maastricht University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maastricht, Netherlands